Threshold analysis and programs for prevention of HIV infection

David R Holtgrave, N. L. Qualls

Research output: Contribution to journalArticle

Abstract

Background. Measuring the economic effectiveness of HIV-infection prevention activities poses special challenges in terms of behavioral change and health outcomes assessment. Methods. One way to address this difficulty is to employ threshold analysis to determine a level of cost per HIV infection averted above which society would seem unwilling to pay. The authors employ a cost-utility analytic framework to determine a monetary threshold for HIV prevention programs, subject base-case results to sensitivity analyses, and apply these results to the Centers for Disease Control and Prevention's fiscal year 1993 budget for extramural HIV prevention programs. Results. The monetary threshold for cost per HIV infection averted was calculated to be $417,000 in 1993 dollars, and ranged from $185,000 to $648,000 depending upon the dollar amount society would be willing to pay per quality-adjusted life year gained. Conclusions. Economic evaluations of particular HIV-infection prevention activities at least can begin by determining whether their levels of effectiveness are above or below this derived monetary threshold, and refinements beyond this dichotomous evaluation can proceed as further data become available.

Original languageEnglish (US)
Pages (from-to)311-317
Number of pages7
JournalMedical Decision Making
Volume15
Issue number4
DOIs
StatePublished - 1995
Externally publishedYes

Fingerprint

HIV Infections
Costs and Cost Analysis
HIV
Quality-Adjusted Life Years
Budgets
Centers for Disease Control and Prevention (U.S.)
Cost-Benefit Analysis
Economics
Outcome Assessment (Health Care)
Health

Keywords

  • AIDS
  • cost-utility analysis
  • HIVE
  • prevention
  • threshold analysis

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Health Informatics
  • Health Information Management
  • Nursing(all)

Cite this

Threshold analysis and programs for prevention of HIV infection. / Holtgrave, David R; Qualls, N. L.

In: Medical Decision Making, Vol. 15, No. 4, 1995, p. 311-317.

Research output: Contribution to journalArticle

@article{5ecc266800b540ca98679bfc5598af7e,
title = "Threshold analysis and programs for prevention of HIV infection",
abstract = "Background. Measuring the economic effectiveness of HIV-infection prevention activities poses special challenges in terms of behavioral change and health outcomes assessment. Methods. One way to address this difficulty is to employ threshold analysis to determine a level of cost per HIV infection averted above which society would seem unwilling to pay. The authors employ a cost-utility analytic framework to determine a monetary threshold for HIV prevention programs, subject base-case results to sensitivity analyses, and apply these results to the Centers for Disease Control and Prevention's fiscal year 1993 budget for extramural HIV prevention programs. Results. The monetary threshold for cost per HIV infection averted was calculated to be $417,000 in 1993 dollars, and ranged from $185,000 to $648,000 depending upon the dollar amount society would be willing to pay per quality-adjusted life year gained. Conclusions. Economic evaluations of particular HIV-infection prevention activities at least can begin by determining whether their levels of effectiveness are above or below this derived monetary threshold, and refinements beyond this dichotomous evaluation can proceed as further data become available.",
keywords = "AIDS, cost-utility analysis, HIVE, prevention, threshold analysis",
author = "Holtgrave, {David R} and Qualls, {N. L.}",
year = "1995",
doi = "10.1177/0272989X9501500402",
language = "English (US)",
volume = "15",
pages = "311--317",
journal = "Medical Decision Making",
issn = "0272-989X",
publisher = "SAGE Publications Inc.",
number = "4",

}

TY - JOUR

T1 - Threshold analysis and programs for prevention of HIV infection

AU - Holtgrave, David R

AU - Qualls, N. L.

PY - 1995

Y1 - 1995

N2 - Background. Measuring the economic effectiveness of HIV-infection prevention activities poses special challenges in terms of behavioral change and health outcomes assessment. Methods. One way to address this difficulty is to employ threshold analysis to determine a level of cost per HIV infection averted above which society would seem unwilling to pay. The authors employ a cost-utility analytic framework to determine a monetary threshold for HIV prevention programs, subject base-case results to sensitivity analyses, and apply these results to the Centers for Disease Control and Prevention's fiscal year 1993 budget for extramural HIV prevention programs. Results. The monetary threshold for cost per HIV infection averted was calculated to be $417,000 in 1993 dollars, and ranged from $185,000 to $648,000 depending upon the dollar amount society would be willing to pay per quality-adjusted life year gained. Conclusions. Economic evaluations of particular HIV-infection prevention activities at least can begin by determining whether their levels of effectiveness are above or below this derived monetary threshold, and refinements beyond this dichotomous evaluation can proceed as further data become available.

AB - Background. Measuring the economic effectiveness of HIV-infection prevention activities poses special challenges in terms of behavioral change and health outcomes assessment. Methods. One way to address this difficulty is to employ threshold analysis to determine a level of cost per HIV infection averted above which society would seem unwilling to pay. The authors employ a cost-utility analytic framework to determine a monetary threshold for HIV prevention programs, subject base-case results to sensitivity analyses, and apply these results to the Centers for Disease Control and Prevention's fiscal year 1993 budget for extramural HIV prevention programs. Results. The monetary threshold for cost per HIV infection averted was calculated to be $417,000 in 1993 dollars, and ranged from $185,000 to $648,000 depending upon the dollar amount society would be willing to pay per quality-adjusted life year gained. Conclusions. Economic evaluations of particular HIV-infection prevention activities at least can begin by determining whether their levels of effectiveness are above or below this derived monetary threshold, and refinements beyond this dichotomous evaluation can proceed as further data become available.

KW - AIDS

KW - cost-utility analysis

KW - HIVE

KW - prevention

KW - threshold analysis

UR - http://www.scopus.com/inward/record.url?scp=0029083479&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029083479&partnerID=8YFLogxK

U2 - 10.1177/0272989X9501500402

DO - 10.1177/0272989X9501500402

M3 - Article

C2 - 8544675

AN - SCOPUS:0029083479

VL - 15

SP - 311

EP - 317

JO - Medical Decision Making

JF - Medical Decision Making

SN - 0272-989X

IS - 4

ER -